New Shepard returns to flight
Posted: Thu, Dec 21, 2023, 2:16 PM ET (1916 GMT)
Blue Origin's New Shepard completed its first suborbital flight in more than 15 months on Tuesday. The vehicle lifted off from the company's West Texas test site at 11:42 am EST (1642 GMT), reaching a peak altitude of 107 kilometers before landing about 10 minutes later. The vehicle carried 33 research payloads and 38,000 postcards from an educational nonprofit organization, but no people. The flight was the first for New Shepard since a mishap in September 2022 on another payload-only flight that was blamed on the structural failure of the vehicle's engine nozzle. The company said it would resume crewed flights of New Shepard "soon" but was not more specific.
Blue Origin's New Shepard completed its first suborbital flight in more than 15 months on Tuesday. The vehicle lifted off from the company's West Texas test site at 11:42 am EST (1642 GMT), reaching a peak altitude of 107 kilometers before landing about 10 minutes later. The vehicle carried 33 research payloads and 38,000 postcards from an educational nonprofit organization, but no people. The flight was the first for New Shepard since a mishap in September 2022 on another payload-only flight that was blamed on the structural failure of the vehicle's engine nozzle. The company said it would resume crewed flights of New Shepard "soon" but was not more specific.
Related Links:
| <<previous article | next article>> |
|
news in brief
|
|
|
|
news links
|
|
Thursday, May 14
The young minds space-proofing ESA’s missions
ESA — 5:44 am ET (0944 GMT) FCC angers small carriers by helping AT&T and Starlink buy EchoStar spectrum
Ars Technica — 5:42 am ET (0942 GMT) Huntsville City Council to consider $45 million investment for Space Command headquarters
WAFF-TV — 5:40 am ET (0940 GMT) Space Force Targeting 2027 Launch For Astroscale Refueling Demo
Aviation Week — 5:40 am ET (0940 GMT) Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease
PR Newswire — 5:39 am ET (0939 GMT) |
